Below are the most recent publications written about "Benzenesulfonates" by people in Profiles.
-
Soare AY, Durham ND, Gopal R, Tweel B, Hoffman KW, Brown JA, O'Brien M, Bhardwaj N, Lim JK, Chen BK, Swartz TH. P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1? in a Human Tonsil Explant Model. J Virol. 2019 01 01; 93(1).
-
Goenka C, Lewis W, Chevres-Fernández LR, Ortega-MartÃnez A, Ibarra-Silva E, Williams M, Franco W. Mobile phone-based UV fluorescence microscopy for the identification of fungal pathogens. Lasers Surg Med. 2019 02; 51(2):201-207.
-
Chattopadhyay A, O'Connor CJ, Zhang F, Galvagnion C, Galloway WR, Tan YS, Stokes JE, Rahman T, Verma C, Spring DR, Itzhaki LS. Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell. Sci Rep. 2016 Apr 05; 6:23732.
-
Tan X, Fuchs BB, Wang Y, Chen W, Yuen GJ, Chen RB, Jayamani E, Anastassopoulou C, Pukkila-Worley R, Coleman JJ, Mylonakis E. The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis. PLoS One. 2014; 9(4):e94468.
-
Hoaglin DC. An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma - a flawed analysis and a problematic response. Expert Opin Pharmacother. 2013 Aug; 14(12):1705-6.
-
Svoboda RM, Mackay D, Welsch MJ, Anderson BE. Multiple cutaneous metastatic chordomas from the sacrum. J Am Acad Dermatol. 2012 Jun; 66(6):e246-7.
-
Hoaglin DC, Cislo PR. An indirect comparison of everolimus versus sorafenib in metastatic renal cell carcinoma - a flawed analysis? Expert Opin Pharmacother. 2012 May; 13(7):1077-8; author reply 1079-80.
-
Saidi RF, Shah SA, Rawson AP, Grossman S, Piperdi B, Bozorgzadeh A. Treating hepatocellular carcinoma with sorafenib in liver transplant patients: an initial experience. Transplant Proc. 2010 Dec; 42(10):4582-4.
-
Bukowski RM, Stadler WM, McDermott DF, Dutcher JP, Knox JJ, Miller WH, Hainsworth JD, Henderson CA, Hajdenberg J, Kindwall-Keller TL, Ernstoff MS, Drabkin HA, Curti BD, Chu L, Ryan CW, Hotte SJ, Xia C, Cupit L, Figlin RA. Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program. Oncology. 2010; 78(5-6):340-7.
-
Sheng Z, Li L, Zhu LJ, Smith TW, Demers A, Ross AH, Moser RP, Green MR. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications. Nat Med. 2010 Jun; 16(6):671-7.